{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:51:30Z","timestamp":1781826690617,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Medical University of Bialystok","doi-asserted-by":"publisher","award":["SUB\/1\/DN\/22\/001\/1104"],"award-info":[{"award-number":["SUB\/1\/DN\/22\/001\/1104"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnrooth Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.118022","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T06:53:04Z","timestamp":1744095184000},"page":"118022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hecate-FSH\u03b233-53C\/S lytic peptide conjugate selectively kills targeted follicle stimulating hormone receptor (FSHR)-positive cancer cells"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-870X","authenticated-orcid":false,"given":"Nafis A.","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Chrusciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-7460","authenticated-orcid":false,"given":"Donata","family":"Ponikwicka-Tyszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9179-0444","authenticated-orcid":false,"given":"Kamila","family":"Pulawska-Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Stelmaszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Doroszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver J.","family":"Kreuzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Rivero-Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Ziecik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slawomir","family":"Wolczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilpo","family":"Huhtaniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118022_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng0993-83","article-title":"Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone","volume":"5","author":"Matthews","year":"1993","journal-title":"Nat. Genet"},{"key":"10.1016\/j.biopha.2025.118022_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0960-0760(95)00049-6","article-title":"The molecular biology of the FSH receptor","volume":"53","author":"Griswold","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118022_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/rep.1.00358","article-title":"FSH and testosterone signaling in Sertoli cells","volume":"130","author":"Walker","year":"2005","journal-title":"Reproduction"},{"key":"10.1016\/j.biopha.2025.118022_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1158\/1078-0432.CCR-16-0492","article-title":"Follicle-stimulating hormone receptor is expressed by most ovarian cancer subtypes and is a safe and effective immunotherapeutic target","volume":"23","author":"Perales-Puchalt","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118022_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192215344","article-title":"Follicle-stimulating hormone promotes the development of endometrial cancer in vitro and in vivo","volume":"19","author":"Sheng","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.biopha.2025.118022_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12155086","article-title":"Pilot study: FSHR expression in neuroendocrine tumors of the appendix","volume":"12","author":"Starzynski","year":"2023","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2025.118022_bib7","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1001283","article-title":"Expression of follicle-stimulating hormone receptor in tumor blood vessels","volume":"363","author":"Radu","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118022_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-015-0128-7","article-title":"Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery","volume":"34","author":"Planeix","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118022_bib9","first-page":"507","article-title":"A novel role for FSH receptor as a tumor endothelial cell marker","volume":"VI","author":"N G","year":"2010","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.biopha.2025.118022_bib10","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2174\/1381612043383971","article-title":"Membrane disrupting lytic peptides for cancer treatments","volume":"10","author":"Leuschner","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2025.118022_bib11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.etap.2013.06.009","article-title":"Melittin: a lytic peptide with anticancer properties","volume":"36","author":"Gajski","year":"2013","journal-title":"Environ. Toxicol. Pharm."},{"key":"10.1016\/j.biopha.2025.118022_bib12","first-page":"177","article-title":"An amphipathic alpha-helical synthetic peptide analogue of melittin inhibits herpes simplex virus-1 (HSV-1)-induced cell fusion and virus spread P","volume":"18","author":"Baghian","year":"1997","journal-title":"eptides"},{"key":"10.1016\/j.biopha.2025.118022_bib13","first-page":"501","article-title":"The morphological effects of two antimicrobial peptides, hecate-1 and melittin, on Escherichia coli","volume":"9","author":"Henk","year":"1995","journal-title":"Scanning Microsc."},{"key":"10.1016\/j.biopha.2025.118022_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2006.11.016","article-title":"Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors","volume":"269","author":"Rivero-Muller","year":"2007","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.biopha.2025.118022_bib15","first-page":"20","article-title":"Targeted destruction of prostate cancer cells and xenografts by lytic peptide-betaLH conjugates","volume":"1","author":"Hansel","year":"2001","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.biopha.2025.118022_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mce.2005.12.056","article-title":"Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo","volume":"260-262","author":"Hansel","year":"2007","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.biopha.2025.118022_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ph16101389","article-title":"The synthetic peptide GA-hecate and its analogs inhibit multiple steps of the Chikungunya virus infection cycle in vitro","volume":"16","author":"Ayusso","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.biopha.2025.118022_bib18","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2174\/0109298665308871240703090408","article-title":"The GA-hecate peptide inhibits the ZIKV replicative cycle in different steps and can inhibit the flavivirus NS2B-NS3 protease after cell infection","volume":"31","author":"da Silva Sanches","year":"2024","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.biopha.2025.118022_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28134884","article-title":"Antiviral evaluation of new synthetic bioconjugates based on GA-hecate: a new class of antivirals targeting different steps of zika virus replication","volume":"28","author":"da Silva Sanches","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118022_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32176-w","article-title":"GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antivirals","volume":"8","author":"Batista","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118022_bib21","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2147\/IDR.S160975","article-title":"Novel vancomycin-peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus","volume":"11","author":"Jelinkova","year":"2018","journal-title":"Infect. Drug Resist"},{"key":"10.1016\/j.biopha.2025.118022_bib22","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/2326-6066.CIR-15-0047","article-title":"Follicle-stimulating hormone receptor as a target in the redirected t-cell therapy for cancer","volume":"3","author":"Urbanska","year":"2015","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.biopha.2025.118022_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.162553","article-title":"A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy","volume":"7","author":"Bordoloi","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2025.118022_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.2001.6558","article-title":"Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo","volume":"85","author":"Gawronska","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2025.118022_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/15353702-0323006-10","article-title":"Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGbeta conjugate: functional characteristic and molecular mechanism of cell death pathway","volume":"230","author":"Bodek","year":"2005","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.biopha.2025.118022_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1593\/neo.04751","article-title":"A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice","volume":"7","author":"Bodek","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.biopha.2025.118022_bib27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1677\/ERC-08-0015","article-title":"Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate","volume":"15","author":"Vuorenoja","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.biopha.2025.118022_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2006.06.017","article-title":"Conjugates of lytic peptides and LHRH or betaCG target and cause necrosis of prostate cancers and metastases","volume":"269","author":"Hansel","year":"2007","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.biopha.2025.118022_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/pros.10259","article-title":"Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors","volume":"56","author":"Leuschner","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2025.118022_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1642-431X(12)60009-6","article-title":"Immune response to lytic peptides conjugated to a betaCG fragment in treated BALB\/C mice","volume":"8","author":"Bogacki","year":"2008","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.biopha.2025.118022_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/1097-0045(20010201)46:2<116::AID-PROS1015>3.0.CO;2-B","article-title":"Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptors","volume":"46","author":"Leuschner","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2025.118022_bib32","first-page":"207","article-title":"Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2\u20320 acetylation by acetic anhydride in aqueous solution","volume":"1","author":"Harper","year":"1975","journal-title":"J. Cycl. Nucleotide Res."},{"key":"10.1016\/j.biopha.2025.118022_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","article-title":"RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues","volume":"14","author":"Wang","year":"2012","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.biopha.2025.118022_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/srep37095","article-title":"Revisiting the expression and function of follicle-stimulation hormone receptor in human umbilical vein endothelial cells","volume":"6","author":"Stelmaszewska","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118022_bib35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1095\/biolreprod62.4.886","article-title":"Development of time-resolved immunofluorometric assays for rat follicle-stimulating hormone and luteinizing hormone and application on sera of cycling rats","volume":"62","author":"van Casteren","year":"2000","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.biopha.2025.118022_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1210\/endo.142.1.7862","article-title":"Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor","volume":"142","author":"Nishi","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2025.118022_bib37","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1016\/S0021-9258(19)34080-3","article-title":"Identification of a follicle-stimulating hormone receptor-binding region in hFSH-beta-(81-95) using synthetic peptides","volume":"265","author":"Santa Coloma","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118022_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0303-7207(91)90123-A","article-title":"A synthetic peptide encompassing two discontinuous regions of hFSH-beta subunit mimics the receptor binding surface of the hormone","volume":"78","author":"Santa-Coloma","year":"1991","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.biopha.2025.118022_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-291X(02)02770-5","article-title":"Multiple roles of cysteine in biocatalysis","volume":"300","author":"Giles","year":"2003","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2025.118022_bib40","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0006-291X(05)80020-8","article-title":"Serine analogues of hFSH-beta-(33-53) and hFSH-beta-(81-95) inhibit hFSH binding to receptor","volume":"184","author":"Santa-Coloma","year":"1992","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2025.118022_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/bbrc.1993.1010","article-title":"An explanation for the disparate effects of synthetic peptides corresponding to human follicle-stimulating hormone beta-subunit receptor binding regions (33-53) and (81-95) and their serine analogs on steroidogenesis in cultured rat Sertoli cells","volume":"190","author":"Grasso","year":"1993","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2025.118022_bib42","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1211\/jpp.60.11.0004","article-title":"Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate","volume":"60","author":"Jia","year":"2008","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.biopha.2025.118022_bib43","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.4049\/jimmunol.153.3.1124","article-title":"Structure-immunogenicity relationship of melittin, its transposed analogues, and D-melittin","volume":"153","author":"King","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118022_bib44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.gene.2015.05.065","article-title":"HEK293 in cell biology and cancer research: phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution","volume":"569","author":"Stepanenko","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2025.118022_bib45","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1095\/biolreprod.105.043471","article-title":"Targeting breast and prostate cancers through their hormone receptors","volume":"73","author":"Leuschner","year":"2005","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.biopha.2025.118022_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1023351819956","article-title":"A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate","volume":"79","author":"Bodek","year":"2003","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.biopha.2025.118022_bib47","article-title":"Anti-tumor effects of targeted follicle-stimulating hormone-lytic peptide conjugates in prostate cancer (PC-3) xenograft mouse model","volume":"1","author":"Aggarwal","year":"2015","journal-title":"Int. J. Cancer Res. Mol. Mech."},{"key":"10.1016\/j.biopha.2025.118022_bib48","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7150\/jca.14425","article-title":"An investigation on a novel anti-tumor fusion peptide of FSH33-53-IIKK","volume":"7","author":"Yang","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2025.118022_bib49","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1210\/er.2012-1014","article-title":"GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies","volume":"33","author":"Limonta","year":"2012","journal-title":"Endocr. Rev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:57:39Z","timestamp":1781823459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":49,"alternative-id":["S0753332225002161"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118022","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hecate-FSH\u03b233-53C\/S lytic peptide conjugate selectively kills targeted follicle stimulating hormone receptor (FSHR)-positive cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118022"}}